Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Fatigue is a common side effect when starting Mounjaro that often peaks in the first few weeks and improves with proper hydration, nutrition, and sleep. However, severe tiredness lasting more than 3–4 weeks or accompanied by symptoms like dizziness, rapid heartbeat, or unintentional weight loss can be a red flag and should prompt medical advice.
There are several factors to consider, so see below for the full Mounjaro fatigue checklist, practical management tips, and clear guidance on when to seek further assessment.
Starting a new medication like Mounjaro (tirzepatide) can bring changes to how you feel day to day. One common concern is Mounjaro fatigue after starting—feeling more tired than usual. This guide helps you understand when fatigue is expected, when it could indicate a problem, and what to do next.
Mounjaro works by mimicking gut hormones (GLP-1 and GIP) that regulate blood sugar and appetite. As your body adjusts, you might notice:
Most people adapt within a few weeks. If fatigue persists or worsens, it's wise to dig deeper.
Fatigue with Mounjaro often falls into two categories:
Expected, mild fatigue
Red-flag fatigue
Use this list to decide if your fatigue is a normal adjustment or a red flag:
If your fatigue checks mostly "normal," try these practical steps:
Flag fatigue as serious if you notice:
At this point, do not wait—seek medical advice promptly.
Be prepared to discuss:
Your doctor may check:
Remember, your health journey with Mounjaro should be safe and effective. If you ever feel something is seriously off or life threatening, don't hesitate—speak to a doctor right away.
(References)
* Dong, H., Liu, W., Lu, Z., & Chen, G. (2022). Adverse events associated with tirzepatide: A systematic review and meta-analysis. *Frontiers in Pharmacology*, *13*, 931495.
* Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. *New England Journal of Medicine*, *387*(3), 205-216.
* Singh, J., et al. (2023). Tirzepatide: A comprehensive review of its use in the treatment of type 2 diabetes mellitus and obesity. *Expert Review of Clinical Pharmacology*, *16*(1), 1-13.
* Min, J., et al. (2022). Safety, tolerability, and efficacy of tirzepatide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. *Diabetes, Obesity and Metabolism*, *24*(8), 1546-1555.
* Coskun, T., et al. (2023). Clinical safety and tolerability of tirzepatide in type 2 diabetes and obesity. *Current Medical Research and Opinion*, *39*(2), 295-309.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.